• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重链成熟的儿科抗体改善HIV-1中和作用的识别决定因素

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.

作者信息

Kumar Sanjeev, Singh Swarandeep, Chatterjee Arnab, Bajpai Prashant, Sharma Shaifali, Katpara Sanket, Lodha Rakesh, Dutta Somnath, Luthra Kalpana

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India.

ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, New Delhi 110067, India.

出版信息

iScience. 2023 Aug 9;26(9):107579. doi: 10.1016/j.isci.2023.107579. eCollection 2023 Sep 15.

DOI:10.1016/j.isci.2023.107579
PMID:37649696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10462834/
Abstract

The structural and characteristic features of HIV-1 broadly neutralizing antibodies (bnAbs) from chronically infected pediatric donors are currently unknown. Herein, we characterized a heavy chain matured HIV-1 bnAb 44m, identified from a pediatric elite-neutralizer. Interestingly, in comparison to its wild-type AIIMS-P01 bnAb, 44m exhibited moderately higher level of somatic hypermutations of 15.2%. The 44m neutralized 79% of HIV-1 heterologous viruses (n = 58) tested, with a geometric mean IC titer of 0.36 μg/mL. The cryo-EM structure of 44m Fab in complex with fully cleaved glycosylated native-like BG505.SOSIP.664.T332N gp140 envelope trimer at 4.4 Å resolution revealed that 44m targets the V3-glycan N332-supersite and GDIR motif to neutralize HIV-1 with improved potency and breadth, plausibly attributed by a matured heavy chain as compared to that of wild-type AIIMS-P01. This study further improves our understanding on pediatric HIV-1 bnAbs and structural basis of broad HIV-1 neutralization by 44m may be useful blueprint for vaccine design in future.

摘要

来自慢性感染儿童供体的HIV-1广谱中和抗体(bnAbs)的结构和特征目前尚不清楚。在此,我们对一种从儿童精英中和者中鉴定出的重链成熟HIV-1 bnAb 44m进行了表征。有趣的是,与其野生型AIIMS-P01 bnAb相比,44m表现出15.2%的体细胞超突变水平略高。44m中和了79%的测试HIV-1异源病毒(n = 58),几何平均IC滴度为0.36 μg/mL。44m Fab与完全切割的糖基化天然样BG505.SOSIP.664.T332N gp140包膜三聚体复合物的冷冻电镜结构在4.4 Å分辨率下显示,44m靶向V3-聚糖N332超位点和GDIR基序,以提高效力和广度中和HIV-1,这可能归因于与野生型AIIMS-P01相比成熟的重链。这项研究进一步增进了我们对儿童HIV-1 bnAbs的理解,44m广泛中和HIV-1的结构基础可能为未来疫苗设计提供有用的蓝图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/db7109c3632b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/dd141f0d25f9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/c7b7886e8cf0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/4d67d9206c4f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/ee5354554a02/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/2ce7fce5c2a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/db7109c3632b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/dd141f0d25f9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/c7b7886e8cf0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/4d67d9206c4f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/ee5354554a02/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/2ce7fce5c2a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/10462834/db7109c3632b/gr5.jpg

相似文献

1
Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.重链成熟的儿科抗体改善HIV-1中和作用的识别决定因素
iScience. 2023 Aug 9;26(9):107579. doi: 10.1016/j.isci.2023.107579. eCollection 2023 Sep 15.
2
An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses.来自 C 型 HIV-1 感染者的广谱中和抗体能有效中和同时代和同源进化的病毒。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01495-18. Print 2019 Feb 15.
3
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.由精英中和抗体诱导的 HIV-1 包膜糖蛋白 SOSIP 三聚体产生的中和抗体反应。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01214-20.
4
Viral Characteristics Associated with Maintenance of Elite Neutralizing Activity in Chronically HIV-1 Clade C-Infected Monozygotic Pediatric Twins.与慢性 HIV-1 型 C 群感染者同卵双胞胎中保持精英中和活性相关的病毒特征。
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00654-19. Print 2019 Sep 1.
5
Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.在多价支架和类天然 gp140 三聚体背景下对保守 HIV-1 中和表位的差异抗体反应
mBio. 2017 Feb 28;8(1):e00036-17. doi: 10.1128/mBio.00036-17.
6
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
7
Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer.通过数字淘选和类天然 gp140 三聚体揭示的聚糖依赖性 HIV-1 广谱中和抗体的隐藏谱系复杂性
Front Immunol. 2017 Aug 24;8:1025. doi: 10.3389/fimmu.2017.01025. eCollection 2017.
8
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite.HIV包膜三聚体引发的自体中和抗体结合了与N332聚糖超位点重叠的区域。
Sci Adv. 2020 Jun 5;6(23):eaba0512. doi: 10.1126/sciadv.aba0512. eCollection 2020 Jun.
9
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.抗体重链和轻链体细胞超突变在赋予 HIV-1 特异性 CAP256-VRC26 bNAb 谱系广度和效力方面的互补作用。
J Virol. 2022 May 25;96(10):e0027022. doi: 10.1128/jvi.00270-22. Epub 2022 May 5.
10
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.中和抗体与非中和抗体对天然样可溶性HIV-1包膜三聚体、未切割的包膜蛋白和单体亚基的差异结合。
Retrovirology. 2014 May 29;11:41. doi: 10.1186/1742-4690-11-41.

引用本文的文献

1
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.通过多种平台稳定的HIV-1 C亚型儿科包膜糖蛋白的设计与免疫原性
Vaccines (Basel). 2025 Jan 22;13(2):110. doi: 10.3390/vaccines13020110.
2
Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.通过多种平台稳定的HIV-1 C亚型儿科包膜糖蛋白的设计与免疫原性
bioRxiv. 2024 Sep 19:2024.09.14.613016. doi: 10.1101/2024.09.14.613016.
3
Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects.

本文引用的文献

1
B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes.对HIV-1儿童精英中和者的B细胞受体库进行测序,鉴定出多种广泛中和抗体克隆型。
Front Immunol. 2024 Feb 16;15:1272493. doi: 10.3389/fimmu.2024.1272493. eCollection 2024.
2
ARMADiLLO: a web server for analyzing antibody mutation probabilities.ARMADiLLO:一个用于分析抗体突变概率的网络服务器。
Nucleic Acids Res. 2023 Jul 5;51(W1):W51-W56. doi: 10.1093/nar/gkad398.
3
An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1.
探索临床前和临床环境中的 HIV 疫苗进展:从历史到未来展望。
Viruses. 2024 Feb 27;16(3):368. doi: 10.3390/v16030368.
4
B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes.对HIV-1儿童精英中和者的B细胞受体库进行测序,鉴定出多种广泛中和抗体克隆型。
Front Immunol. 2024 Feb 16;15:1272493. doi: 10.3389/fimmu.2024.1272493. eCollection 2024.
针对HIV-1不同表位的人类抗HIV-1中和抗体概述。
ACS Omega. 2023 Feb 15;8(8):7252-7261. doi: 10.1021/acsomega.2c07933. eCollection 2023 Feb 28.
4
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.通过一种广泛中和的 SARS-CoV-2 抗体对奥密克戎变异株 BA.1、BA.2、BA.4 和 BA.5 的中和作用的结构见解。
Sci Adv. 2022 Oct 7;8(40):eadd2032. doi: 10.1126/sciadv.add2032. Epub 2022 Oct 5.
5
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.人类免疫球蛋白库分析指导设计针对 HIV V2-顶点广谱中和抗体前体的疫苗起始免疫原。
Immunity. 2022 Nov 8;55(11):2149-2167.e9. doi: 10.1016/j.immuni.2022.09.001. Epub 2022 Sep 29.
6
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.高热稳定性可增强天然样HIV-1包膜三聚体诱导的中和抗体反应。
NPJ Vaccines. 2022 Feb 28;7(1):27. doi: 10.1038/s41541-022-00446-4.
7
Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.HIV-1特异性广泛中和抗体和多克隆血浆对严重急性呼吸综合征冠状病毒2的交叉中和作用
PLoS Pathog. 2021 Sep 24;17(9):e1009958. doi: 10.1371/journal.ppat.1009958. eCollection 2021 Sep.
8
Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.联合抗逆转录病毒疗法对 C 型人类免疫缺陷病毒感染儿童的 1 型特异性抗体反应的影响。
J Gen Virol. 2020 Dec;101(12):1289-1299. doi: 10.1099/jgv.0.001480. Epub 2020 Sep 11.
9
Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection.广谱中和血浆抗体对多变异 HIV-1 感染婴儿体内自身循环病毒有效。
Nat Commun. 2020 Sep 2;11(1):4409. doi: 10.1038/s41467-020-18225-x.
10
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.婴儿来源的 HIV-1 包膜糖蛋白中的一个罕见突变改变了二聚体间的稳定性,并影响了针对三聚体顶部的广谱中和抗体的敏感性。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00814-20.